Collaboration of pharmaceutical companies with anti-doping officers

Nowadays many pharmaceutical companies are ready to collaborate with anti-doping officers in their war on intake of prohibited preparations in sports. It sounds strange but it is the reality. In fact, if you review the fate of EPO, you can understand why drug manufacturers agree to support efforts of anti-doping agencies. EPO is actually an effective remedy for treatment of anemia. Numerous persons with anemia that have taken EPO have been treated. But what do you think while hearing about this medicine? Almost every individual associates this remedy just with doping in sports. This product has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. So, EPO is associated just with lying, disgrace, etc. Looking at this case, drug manufacturers try to “defend” their medicines from the similar fate. That’s why they work together with anti-doping officials.
Although certain pharmaceutical companies began to cooperate with anti-doping officials earlier, sometimes there were certain problems between them. Anti-doping officials criticized some pharmaceutical companies for their links to doping.
Nowadays relations between anti-doping agencies and pharmaceutical companies are better. Drug manufacturers share detailed information about new medicines with anti-doping agencies. It is valuable information for development of detection tests for these products. While anti-doping officials learn how drugs are manufactured, how they pass into body, how they work in the body, they can develop more efficacious tests for these drugs.
For example, the company Roche that introduced the medication CERA helped anti-doping agencies to introduce a detection test for it. Later other drug manufacturers followed the example of Roche. The company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during Olympics in London.
While relations between anti-doping officers and huge pharmaceutical companies become closer, smaller pharmaceutical companies started to collaborate with anti-doping agencies too. While earlier drug manufacturers haven’t wanted to discuss about their relations with anti-doping officers publicly, today they don’t fear to announce about this aspect.